Detalles de la búsqueda
1.
Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial.
Ann Surg
; 278(3): 320-327, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37325931
2.
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.
Future Oncol
; 17(34): 4665-4676, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636255
3.
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.
Breast Cancer Res
; 21(1): 142, 2019 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31829264
4.
Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance).
Ann Surg
; 266(4): 667-676, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28657941
5.
Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype.
Oncologist
; 22(4): 394-401, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28314842
6.
Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.
Proc Natl Acad Sci U S A
; 109(15): 5832-7, 2012 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22460789
7.
Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing.
Cancer Cytopathol
; 131(5): 289-299, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36650408
8.
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials.
Nat Commun
; 14(1): 7053, 2023 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37923752
9.
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial.
Cancers (Basel)
; 15(13)2023 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444385
10.
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.
Ther Adv Med Oncol
; 15: 17588359231189422, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37547448
11.
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
JAMA Netw Open
; 6(12): e2349646, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38153734
12.
Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer.
Front Psychol
; 13: 856813, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35903747
13.
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.
Cancers (Basel)
; 14(5)2022 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267631
14.
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.
Clin Cancer Res
; 27(19): 5365-5375, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253579
15.
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
NPJ Breast Cancer
; 6: 15, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32436923
16.
Simulating Time-Dependent Patterns of Nonadherence by Patients With Breast Cancer to Adjuvant Oral Endocrine Therapy.
JCO Clin Cancer Inform
; 3: 1-9, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31002563
17.
Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trial.
BMC Med Genomics
; 5: 51, 2012 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23158478
18.
Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.
Cancer
; 117(1): 39-47, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20740500
19.
Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.
J Natl Cancer Inst
; 103(3): 264-72, 2011 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-21191116
20.
Genomic grade index is associated with response to chemotherapy in patients with breast cancer.
J Clin Oncol
; 27(19): 3185-91, 2009 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19364972
Resultados
1 -
20
de 20
1
Próxima >
>>